Condition: HNSCC
Interventions: Drug: Cetuximab; Drug: avelumab; Drug: Cisplatin; Radiation: IMRT
Sponsors: Groupe Oncologie Radiotherapie Tete et Cou; Merck Sharp & Dohme Corp.; Pfizer
Not yet recruiting - verified December 2016
http://ift.tt/2hTfzrQ
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου